Related references
Note: Only part of the references are listed.Molecular Imaging Targeting Corticotropin-releasing Hormone Receptor for Corticotropinoma: A Changing Paradigm
Rama Walia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly
Waiel A. Bashari et al.
NEUROSURGICAL FOCUS (2020)
The Clinical Impact of [68Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting Tumours
Taweesak Wannachalee et al.
CLINICAL ENDOCRINOLOGY (2019)
Utility of 13N-Ammonia PET/CT to Detect Pituitary Tissue in Patients with Pituitary Adenomas
Zongming Wang et al.
ACADEMIC RADIOLOGY (2019)
CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease
Jacqueline Boyle et al.
ENDOCRINE (2019)
PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study
Hao Wang et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma
Celine Heimburger et al.
CLINICAL NUCLEAR MEDICINE (2018)
High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
Felix Behling et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Accumulation of 11C-methionine in the normal pituitary gland on 11C-methionine PET
Noriaki Tomura et al.
ACTA RADIOLOGICA (2017)
Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management
Benjamin G. Challis et al.
ENDOCRINE CONNECTIONS (2017)
Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse
Anna Margherita Maffione et al.
CLINICAL NUCLEAR MEDICINE (2016)
Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas
Zize Feng et al.
CLINICAL NUCLEAR MEDICINE (2016)
Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI
Olympia Koulouri et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Localisation of an occult thyrotropinoma with 11C-methionine PET-CT before and after somatostatin analogue therapy
Olympia Koulouri et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome
Olympia Koulouri et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
High-resolution 18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease
Prashant Chittiboina et al.
JOURNAL OF NEUROSURGERY (2015)
Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants
Athar Haroon et al.
NUCLEAR MEDICINE COMMUNICATIONS (2015)
Pituitary-directed medical therapy in Cushing's disease
Stephan Petersenn et al.
PITUITARY (2015)
Improvement in Diagnosis of Metastatic Pituitary Carcinoma by 68Ga DOTATATE PET/CT
Jianqi Xiao et al.
CLINICAL NUCLEAR MEDICINE (2014)
Comparison of 68Ga DOTATATE to 18F-FDG Uptake Is Useful in the Differentiation of Residual or Recurrent Pituitary Adenoma From the Remaining Pituitary Tissue After Transsphenoidal Adenomectomy
Xiaobin Zhao et al.
CLINICAL NUCLEAR MEDICINE (2014)
Clinical Usefulness of Coregistered 11C-Methionine Positron Emission Tomography/3-T Magnetic Resonance Imaging at the Follow-Up of Acromegaly
Sandra Rodriguez-Barcelo et al.
WORLD NEUROSURGERY (2014)
Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions
Hannah Seok et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2013)
A Very Rare Case of Nonfunctioning Pituitary Adenoma Incidentally Disclosed at 18F-FDG PET/CT
Pietro Maffei et al.
CLINICAL NUCLEAR MEDICINE (2012)
Update on Pituitary Surgery
Brooke Swearingen
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Acromegaly revealed by 18FDG-PET/CT in a plasmocytoma patient
Jean-Christophe Maiza et al.
PITUITARY (2012)
Incidental Focal 18F-FDG Uptake in the Pituitary Gland: Clinical Significance and Differential Diagnostic Criteria
Seung Hyup Hyun et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
The genetics of pituitary adenomas
Silvia Vandeva et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Occult Prolactinoma Diagnosed by FDG PET/CT
Filip Gemmel et al.
CLINICAL NUCLEAR MEDICINE (2010)
Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study
Shin Young Jeong et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma Clinical article
Hidetoshi Ikeda et al.
JOURNAL OF NEUROSURGERY (2010)
F-18-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer
Orazio Schillaci et al.
NUCLEAR MEDICINE COMMUNICATIONS (2010)
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Beverly M. K. Biller et al.
BMC ENDOCRINE DISORDERS (2010)
PET/MRI system design
Gaspar Delso et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease
Ali S. Alzahrani et al.
PITUITARY (2009)
11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas
BNT Tang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Positron emission tomography in acromegaly and other pituitary adenoma patients
Carin Muhr
NEUROENDOCRINOLOGY (2006)
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: Update after an additional 10 years
G Minniti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Somatostatin analogs as radiodiagnostic tools
WW de Herder et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2005)
The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours
MJ Acosta-Gómez et al.
BRITISH JOURNAL OF RADIOLOGY (2005)
The role of [18F]fluorodeoxyglucose positron emission tomography and [111In]diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome
K Pacak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome
S Tsagarakis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Serendipitous detection of Cushing's disease by FDG positron emission tomography and a review of the literature
T Komori et al.
CLINICAL NUCLEAR MEDICINE (2002)
Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo
S Nielsen et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2001)
In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics:: Correlation with somatostatin and dopamine D2 receptor scintigraphy
D Ferone et al.
CLINICAL ENDOCRINOLOGY (2001)
Share Paper
